These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20973248)

  • 21. [Use of antithrombotic agents in peripheral arterial diseases].
    Wütschert R; Bounameaux H
    Arch Mal Coeur Vaiss; 1996 Nov; 89(11 Suppl):1551-5. PubMed ID: 9092417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Smoking cessation has no influence on quality of life in patients with peripheral arterial disease 5 years post-vascular surgery.
    Hoogwegt MT; Hoeks SE; Pedersen SS; Scholte op Reimer WJ; van Gestel YR; Verhagen HJ; Poldermans D
    Eur J Vasc Endovasc Surg; 2010 Sep; 40(3):355-62. PubMed ID: 20580273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Re: Secondary medical prevention in patients with peripheral arterial disease.
    Schouten O; Welten GM; Bax JJ; Poldermans D
    Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):59-60. PubMed ID: 17719805
    [No Abstract]   [Full Text] [Related]  

  • 24. Peripheral arterial disease: a review of disease awareness and management.
    Watson K; Watson BD; Pater KS
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):365-79. PubMed ID: 17296541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic antiatherosclerotic treatment for the peripheral arterial occlusive disease patient.
    Baumgartner I
    Expert Opin Pharmacother; 2005 Oct; 6(13):2181-92. PubMed ID: 16218880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ethical considerations in cardiovascular prevention.
    Follath F
    Fundam Clin Pharmacol; 2009 Dec; 23(6):669-73. PubMed ID: 19500153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medication underuse during long-term follow-up in patients with peripheral arterial disease.
    Hoeks SE; Scholte op Reimer WJ; van Gestel YR; Schouten O; Lenzen MJ; Flu WJ; van Kuijk JP; Latour C; Bax JJ; van Urk H; Poldermans D
    Circ Cardiovasc Qual Outcomes; 2009 Jul; 2(4):338-43. PubMed ID: 20031859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structured surveillance of patients with peripheral arterial occlusive disease after peripheral vascular interventions.
    Weiss N; Bergert H
    Vasa; 2009 Nov; 38(4):302-15. PubMed ID: 19998251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal risk factor modification and medical management of the patient with peripheral arterial disease.
    Chi YW; Jaff MR
    Catheter Cardiovasc Interv; 2008 Mar; 71(4):475-89. PubMed ID: 18307227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetic foot: prevention and interventions.
    Venermo M; Lepäntalo M
    Angiol Sosud Khir; 2008; 14(3):19-31. PubMed ID: 19791427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of prior peripheral arterial disease and stroke on outcomes of acute coronary syndromes and effect of evidence-based therapies (from the Global Registry of Acute Coronary Events).
    Mukherjee D; Eagle KA; Kline-Rogers E; Feldman LJ; Juliard JM; Agnelli G; Budaj A; Avezum A; Allegrone J; FitzGerald G; Steg PG;
    Am J Cardiol; 2007 Jul; 100(1):1-6. PubMed ID: 17599431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cardiovascular polypill in high risk patients].
    Lafeber M; Spiering W; Bots ML; de Valk V; Visseren FL; Grobbee DE
    Ned Tijdschr Geneeskd; 2011; 155(44):A3070. PubMed ID: 22067559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Current progress in the treatment for diabetic retinopathy in internal medicine].
    Hamada Y
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():173-7. PubMed ID: 12430225
    [No Abstract]   [Full Text] [Related]  

  • 34. Comprehensive medical management of peripheral arterial disease.
    Gandhi S; Weinberg I; Margey R; Jaff MR
    Prog Cardiovasc Dis; 2011; 54(1):2-13. PubMed ID: 21722781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacotherapy before and after revascularization: anticoagulation, antiplatelet agents, and statins.
    Dagher NN; Modrall JG
    Semin Vasc Surg; 2007 Mar; 20(1):10-4. PubMed ID: 17386359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Medical treatment of patients with clinical peripheral arterial disease at hospital discharge: compliance with the French guidelines and changing practices (COPART I registry)].
    Béraut E; Cambou JP; Guilhem JM; Vaysse N; Labro S; Séverac D; Boccalon H; Bura-Rivière A
    J Mal Vasc; 2008 Feb; 33(1):1-11. PubMed ID: 18187280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-platelet therapy: is it all over in peripheral artery disease?
    Jaipersad AS; Silverman SH; Lip GY
    Thromb Haemost; 2010 Apr; 103(4):689-91. PubMed ID: 20174749
    [No Abstract]   [Full Text] [Related]  

  • 38. Comments regarding 'Measuring effects of smoking and smoking cessation in patients with vascular disease'.
    Lindström D
    Eur J Vasc Endovasc Surg; 2010 Sep; 40(3):363-4. PubMed ID: 20598921
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of statin therapy on mortality in patients with peripheral arterial disease and comparison of those with versus without associated chronic obstructive pulmonary disease.
    van Gestel YR; Hoeks SE; Sin DD; Simsek C; Welten GM; Schouten O; Stam H; Mertens FW; van Domburg RT; Poldermans D
    Am J Cardiol; 2008 Jul; 102(2):192-6. PubMed ID: 18602520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overcoming aspirin resistance: increased platelet inhibition with combination aspirin and clopidogrel and high dose aspirin therapy in aspirin resistant patients with peripheral vascular disease.
    Wong S; Morel-Kopp MC; Chen Q; Appleberg M; Ward CM; Lewis DR
    Thromb Haemost; 2006 Jun; 95(6):1042-3. PubMed ID: 16732389
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.